Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

49
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
49
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.7K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

35
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
35
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

30
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
30

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiomic MRI model for predicting the development of worrisome features in branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs).

La Radiologia medica·2026
Same author

Teaching parathyroid-sparing thyroidectomy: Clinical and educational impact of near-infrared autofluorescence. Results of a retrospective case-control study.

Surgery·2026
Same author

Prognostic factors and survival after recurrence in major salivary gland carcinomas: a multicenter study.

Oral oncology·2026
Same author

CD44+ and CD133+ Extracellular Vesicles as Future Potential Targets in Gastrointestinal Tumor.

Frontiers in bioscience (Landmark edition)·2026
Same author

Protective Effects of Plant-Based Diets Against Colorectal Carcinogenesis via Modulation of Key Cellular and Molecular Mechanisms: A Comprehensive Review of Evidence.

Current oncology (Toronto, Ont.)·2026
Same author

Targeting RuvBL1 disrupts mitochondrial metabolism and structure in hepatocellular carcinoma.

JHEP reports : innovation in hepatology·2026

Related Experiment Video

Updated: May 6, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

2.1K

Environmental pollution: a tangible risk for NAFLD pathogenesis.

Mario Arciello1, Manuele Gori, Roberta Maggio

  • 1Francesco Balsano Foundation, via G.B. Martini 6, Rome 00198, Italy. clara.balsano@cnr.it.

International Journal of Molecular Sciences
|November 12, 2013
PubMed
Summary
This summary is machine-generated.

Environmental pollutants are emerging as significant risk factors for nonalcoholic fatty liver disease (NAFLD). Understanding their impact on liver health is crucial for developing new interventions against this widespread condition.

More Related Videos

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
08:20

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

1.9K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.8K

Related Experiment Videos

Last Updated: May 6, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

2.1K
Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
08:20

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

1.9K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.8K

Area of Science:

  • Hepatology
  • Environmental Health
  • Toxicology

Background:

  • The liver is vital for overall health, but susceptible to diseases like nonalcoholic fatty liver disease (NAFLD).
  • NAFLD is a complex condition linked to metabolic issues, increasingly prevalent due to lifestyle changes.
  • Industrialization releases environmental pollutants (pesticides, solvents, particulate matter) impacting health.

Purpose of the Study:

  • To review the impact of environmental pollutants on liver health.
  • To highlight pollutants as potential risk factors for NAFLD.
  • To emphasize the need for understanding molecular mechanisms and interventions.

Main Methods:

  • Literature review of studies on environmental pollutants and liver health.
  • Analysis of evidence linking contaminants to NAFLD pathogenesis.
  • Synthesis of current knowledge on pollutant-induced steatogenesis.

Main Results:

  • Growing evidence links environmental pollutants to increased NAFLD risk.
  • These contaminants possess significant steatogenic potential.
  • Pollutants contribute to the multifactorial nature of NAFLD.

Conclusions:

  • Environmental pollutants are tangible risk factors for NAFLD.
  • Further research into molecular mechanisms is urgently needed.
  • Interventions to reduce pollutant diffusion are essential for public health.